| Pharmaceutical Information |
| Drug Name |
Clorazepate dipotassium |
| Drug ID |
BADD_D00506 |
| Description |
A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. |
| Indications and Usage |
For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Also used as adjunctive therapy in the management of partial seizures and for the symptomatic relief of acute alcohol withdrawal. |
| Marketing Status |
approved; illicit |
| ATC Code |
Not Available |
| DrugBank ID |
DB00628
|
| KEGG ID |
D00694
|
| MeSH ID |
D003009
|
| PubChem ID |
167305
|
| TTD Drug ID |
D0P3JU
|
| NDC Product Code |
70954-157; 72789-256; 13107-320; 43063-893; 13107-321; 51672-4044; 70954-159; 13107-319; 70954-158; 51672-4043; 60505-4755; 72603-114; 72603-112; 72603-113; 12828-0019; 51672-4042; 60505-4756; 69037-0067; 60505-4754; 58159-097 |
| UNII |
63FN7G03XY
|
| Synonyms |
Clorazepate Dipotassium | Dipotassium Chlorazepate | 4306-CB | Chlorazepate | Clorazepate | Tranxene | Tranxilium | Clorazepic Acid | Clorazepate Monopotassium |
|
| Chemical Information |
| Molecular Formula |
C16H11ClK2N2O4 |
| CAS Registry Number |
57109-90-7 |
| SMILES |
C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)[O-].[OH-].[K+].[K+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
